Website
N/ATelephone
61.2.9247.4144
Address
Level 8, Suite 2 66 Clarence Street Sydney, New South Wales (NSW) 2000
Description
Uscom Ltd. engages in the development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices. It operates through the following geographical segments: Australia, Asia, Americas, Europe, and Other Regions. The company was founded by Robert Allan Phillips on December 23, 1999 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.05
Trade Value (12mth)
AU$182.00
1 week
0%
1 month
-16.33%
YTD
-18%
1 year
-19.61%
All time high
3.86087
EPS 3 yr Growth
63.000%
EBITDA Margin
-95.10%
Operating Cashflow
-$1m
Free Cash Flow Return
-26.10%
ROIC
-47.50%
Interest Coverage
-24.60
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
187m
HALO Sector
Healthcare
Next Company Report Date
19-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Change of Director's Interest Notice - Phillips
×
Change of Director's Interest Notice - Phillips |
31 October 22 |
Change of Registry Address
×
Change of Registry Address |
31 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 August 11 |
Preliminary and Annual Report to shareholders
×
Preliminary and Annual Report to shareholders |
31 August 10 |
Preliminary and Annual Report to shareholders
×
Preliminary and Annual Report to shareholders |
30 September 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 September 22 |
Letter to Shareholders re AGM
×
Letter to Shareholders re AGM |
30 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 November 16 |
Uscom 2016 AGM Presentation
×
Uscom 2016 AGM Presentation |
30 May 12 |
Uscom Presentation
×
Uscom Presentation |
30 March 22 |
Completion of small share parcels consolidation
×
Completion of small share parcels consolidation |
30 August 13 |
Preliminary and Annual Report to shareholders
×
Preliminary and Annual Report to shareholders |
30 August 12 |
Preliminary and Annual Report to shareholders
×
Preliminary and Annual Report to shareholders |
30 August 07 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 September 20 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 October 20 |
Uscom 2020 AGM Presentation
×
Uscom 2020 AGM Presentation |
29 August 16 |
2016 Annual Results Investors Presentation
×
2016 Annual Results Investors Presentation |
29 April 22 |
Uscom to Present at NWR Virtual Investor Conference
×
Uscom to Present at NWR Virtual Investor Conference |
28 September 17 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 September 10 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 October 16 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 November 18 |
Uscom Ltd 2018 AGM Presentation
×
Uscom Ltd 2018 AGM Presentation |
28 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 July 21 |
Uscom to present at NWR Communications Virtual Investor Conf
×
Uscom to present at NWR Communications Virtual Investor Conf |
28 August 09 |
Preliminary and Annual Report to shareholders
×
Preliminary and Annual Report to shareholders |
28 April 22 |
AIR FDA 510K Filed and New US Distribution
×
AIR FDA 510K Filed and New US Distribution |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.